BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3954782)

  • 1. Mechanism of potentiation of antitumor activity of 5-fluorouracil against adenocarcinoma 755 by L-cysteine.
    Iigo M; Hoshi A
    Biochem Pharmacol; 1986 Mar; 35(5):727-30. PubMed ID: 3954782
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.
    Spiegelman S; Nayak R; Sawyer R; Stolfi R; Martin D
    Cancer; 1980 Mar; 45(5 Suppl):1129-34. PubMed ID: 7357507
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in mice.
    Iigo M; Nakajima Y; Hoshi A; De Clercq E
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):773-7. PubMed ID: 3115784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of potentiation of antitumor activity of 5-fluorouracil by guanine ribonucleotides against adenocarcinoma 755.
    Iigo M; Yamaizumi Z; Nishimura S; Hoshi A
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):1059-65. PubMed ID: 3665991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism and pharmacology of 5-fluorouracil.
    Miller E
    J Surg Oncol; 1971; 3(3):309-15. PubMed ID: 4942414
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of bleomycin by an antifungal polyene, pentamycin, in transformed animal cells.
    Nakashima T; Kuwano M; Matsui K; Komiyama S; Hiroto I
    Cancer Res; 1974 Dec; 34(12):3258-61. PubMed ID: 4138969
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts.
    Kopper L; Magyarosy E; Jeney A; Lapis K; Szabolcs A; Otvös L
    Oncology; 1984; 41(3):155-8. PubMed ID: 6328393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.
    Nadal JC; Van Groeningen CJ; Pinedo HM; Peters GJ
    Biomed Pharmacother; 1988; 42(6):387-93. PubMed ID: 3064823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic activity of L-histidinol against spontaneous, autochthonous murine breast tumors.
    Stolfi RL; Martin DS
    Chemotherapy; 1990; 36(6):435-40. PubMed ID: 2292205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dosage and infusion time on the incorporation of 5-fluorouracil into DNA and RNA of normal tissues and an adenocarcinoma transplanted to rat liver.
    Erichsen C; Christensson PI; Jacobsson B; Jönsson PE; Stenram U
    J Surg Oncol; 1988 Jul; 38(3):155-9. PubMed ID: 2455851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of thymidine in biochemical modulation: a review.
    O'Dwyer PJ; King SA; Hoth DF; Leyland-Jones B
    Cancer Res; 1987 Aug; 47(15):3911-9. PubMed ID: 3300957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the action of fluorouracil on leukemia cells.
    Goldberg AR; Machledt JH; Pardee AB
    Cancer Res; 1966 Aug; 26(8):1611-5. PubMed ID: 5923159
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil against adenocarcinoma 755 in mice. Increased therapeutic index and correlation with increased plasma 5-fluorouracil levels.
    Iigo M; Araki E; Nakajima Y; Hoshi A; De Clercq E
    Biochem Pharmacol; 1988 Apr; 37(8):1609-13. PubMed ID: 3358790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation.
    Spiegelman S; Sawyer R; Nayak R; Ritzi E; Stolfi R; Martin D
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4966-70. PubMed ID: 6933541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
    Sartorelli AC; Booth BA
    Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response.
    Ardalan B; Buscaglia MD; Schein PS
    Biochem Pharmacol; 1978; 27(16):2009-13. PubMed ID: 718724
    [No Abstract]   [Full Text] [Related]  

  • 18. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor potency of oral tegafur against adenocarcinoma 755 in mice is markedly enhanced by oral (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Iigo M; Yamaizumi Z; Nishimura S; Hoshi A; De Clercq E
    Jpn J Cancer Res; 1987 Apr; 78(4):409-13. PubMed ID: 3108221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
    el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
    In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.